tm logo
LUMVYTA
Dead/Abandoned
ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE

failure to respond or late response

on 24 Jun 2023

Last Applicant/ Owned by

2000 Sierra Point Parkway

Brisbane

CA

94005

Serial Number

97417578 filed on 18th May 2022

Registration Number

N/A

Correspondent Address

Connie L. Ellerbach

FENWICK & WEST LLP

SILICON VALLEY CENTER

801 CALIFORNIA STREET

MOUNTAIN VIEW CA 94041

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

LUMVYTA

Pharmaceutical preparations; pharmaceutical preparations for human use; pharmaceutical preparation for the prevention and treatment of cancer; pharmaceutical preparations for the treatment of oncological diseases; pharmaceutical preparations and substances for the prevention and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunRead More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations; pharmaceutical preparations for human use; pharmaceutical preparation for the prevention and treatment of cancer; pharmaceutical preparations for the treatment of oncological diseases; pharmaceutical preparations and substances for the prevention and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; targeted medical preparations for use in the field of cancer prevention and treatment; medical and veterinary preparations for the delivery of compounds to the body for the treatment and prevention of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

Class [044]
Medical, Beauty & Agricultural Services


Medical information services; healthcare services; research, development, and evaluation of pharmaceutical preparations for the prevention and treatment of cancer; laboratory analysis and research of drugs and pharmaceutical products; research and development services in the fields of oncology, immunotherapy, chemotherapy, and combination therapies for the treatment of cancer and tumors; providing medical research information in the fields of oncology, immunotherapy, chemotherapy and combination therapies; scientific advisory services, namely, providing scientific information, advice, and consultancy in the field of cancer treatment; healthcare services, namely, providing cancer treatment information to physicians, health care professionals, and patients; design, development, research, and testing of drugs and pharmaceuticals for the treatment and/or prevention of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; medical information services, namely, providing information regarding viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

Mark Details


Serial Number

No 97417578

Mark Type

No Service Mark

Attorney Docket Number

No 37942-00070

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
26th Jun 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
24th Jun 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
24th Jun 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
08th Mar 2023NON-FINAL ACTION WRITTEN
08th Mar 2023NON-FINAL ACTION E-MAILED
08th Mar 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
07th Mar 2023ASSIGNED TO EXAMINER
14th Sep 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
14th Sep 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
14th Sep 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED